Rx drug information, pharmaceutical research, clinical trials, news, and more
MESNA INJECTION Mesna Injection is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide.
Mesna is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.
Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial. [2008.07]
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial. [2008.03.12]
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. [2007.11]
Effects of Mesna on Homocysteine in Kidney Failure [Completed]
MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application [Completed]
A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [Completed]
Vasodilators and Anti-Oxidant Therapy in Early ATN [Not yet recruiting]
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Active, not recruiting]
-- advertisement --
All Rights reserved - Copyright DrugLib.com, 2006-2008